SCHEMBL26856997

SCHEMBL26856997

Nc1nc2ccc(-c3csc(C(=O)NCC4CCOC4)c3)cn2n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 2/20 0.44
▸ MAPK10 P53779 2/20 0.44
▸ PIK3CA P42336 2/20 0.43
▸ PIK3CG P48736 2/20 0.43
▸ ADORA2A P29274 2/20 0.41
▸ ADORA1 P30542 2/20 0.41
▸ MMP12 P39900 6/20 0.40
▸ TTK P33981 2/20 0.40
▸ MAPK9 P45984 1/20 0.38
▸ GSK3B P49841 3/20 0.38
▸ KCNH2 Q12809 3/20 0.38
▸ METTL3 Q86U44 1/20 0.38
▸ NAMPT P43490 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26856933 0.95 PIK3CA (0.46) MAPK8MAPK10PIK3CAPIK3CGADORA2A
SCHEMBL26856958 0.95 PIK3CA (0.42) MAPK8MAPK10PIK3CAPIK3CGADORA2A
SCHEMBL26856937 0.89 PIK3CG (0.48) PIK3CAPIK3CGADORA2AADORA1MMP12
SCHEMBL26856995 0.89 MMP12 (0.40) PIK3CAPIK3CGMMP12TTKMETTL3
SCHEMBL26856930 0.88 PIK3CG (0.47) PIK3CAPIK3CGADORA2AADORA1MMP12
SCHEMBL26857060 0.86 TTK (0.45) MAPK8MAPK10PIK3CAPIK3CGMMP12
SCHEMBL26856929 0.85 MAPK8 (0.41) MAPK8MAPK10PIK3CAPIK3CGMMP12
SCHEMBL26856936 0.85 HPGD (0.47) —
SCHEMBL26856993 0.84 HPGD (0.44) PIK3CAPIK3CGMMP12
SCHEMBL26856924 0.83 MAPK3 (0.45) MAPK8MAPK10PIK3CAPIK3CGMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382904-A1 SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF SNCA, PSEN2, PARK7 MAPK8 3191/4885MAPK10 3949/4885PIK3CA 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback